Study: CBD Cream Effective in Treating Symptoms of Back Pain
Newly released research shows that those with chronic back pain may want to seriously considering using CBD cream to treat their symptoms.
A study published in the Journal of Opioid Management, and epublished by the National Institute of Health, has found that hemp-derived cannabidiol (CBD) cream is directly associated with pain-relieving effects in study participants who have chronic back pain.
For the case report researchers used commercially sold and transdermal formulation of CBD – specifically they used Baskin Essentials Body Wellness Cream – in two individuals. Both individuals with chronic back pain reported experiencing “significant symptom and pain relief” just minutes or hours after using the CBD cream. The study found that these pain-reliving effects lasted between eight and ten hours.
The study concludes by stating that “This case series suggests that CBD may have antinociceptive and anti-inflammatory effects on opioid-naive patients with neuropathic and radicular pain”, noting that “we believe further investigation is warranted to see if these products have a role in the treatment of acute and chronic pain.”
The full abstract of the study can be found below:
Objective: Two patient case reports are presented describing the use of cannabidiol (CBD) for the symptomatic relief of a lumbar compression fracture and in the mitigation of thoracic discomfort and dysesthesia secondary to a surgically resected meningioma.
Discussion: CBD appears to have antisnociceptive and anti-inflammatory effects on opioid-naive patients with neuro-pathic and radicular pain. Of note, the patients in this case series used the same CBD cream: Baskin Essentials Body Wellness Cream (400 mg CBD per two oz.) Conclusion: Hemp-derived CBD in a transdermal cream provided significant symptom and pain relief for the patients described in this case series. Based on these results, we believe further investigation is warranted to see if CBD-containing products should have a more prominent role in the treatment of acute and chronic pain.
The study’s affiliations can be found below:
Department of Anesthesiology and Pain Medicine, Portsmouth Anesthesia Associates, Ports-mouth, Virginia.
Department of Chemistry, University of California, San Diego, California.
Department of Chemistry, University of California, Berkeley, California.
Department of Anesthesiology, Louisiana State University Health Sciences Center-Shreveport, Shreve-port, Louisiana.
Department of Anesthesiology and Pharmacology, Louisiana State University School of Medicine, New Or-leans, Louisiana.
According to a study published earlier this year in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with chronic pain. The study is titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial.